首页> 美国卫生研究院文献>Radiation Oncology Journal >Clinical and radiobiological consideration of cyclical hypofractionated radiation therapy also known as QUAD Shot for neglected skin cancer disfiguring the face of a non-compliant patient who was refusing surgery and protracted radiation therapy: case report
【2h】

Clinical and radiobiological consideration of cyclical hypofractionated radiation therapy also known as QUAD Shot for neglected skin cancer disfiguring the face of a non-compliant patient who was refusing surgery and protracted radiation therapy: case report

机译:周期性低剂量放疗也被称为QUAD Shot的临床和放射生物学考虑因素可治疗被忽视的皮肤癌使拒绝接受手术和长期放疗的不依从患者的面部容貌受损:病例报告

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Although surgery is the mainstay of local treatment for skin cancer, definitive radiation therapy (RT) has been also applied for patients who are unable to tolerate surgery. Definitive RT regimens usually consist of daily treatment for 4–7 weeks. Such protracted daily RT regimens, however, would not be feasible for non-compliant patients or patients who are unable to make multiple daily trips for weeks. Without treatment, however, skin cancers can continuously progress and cause distressing symptoms. A cyclical hypofractionated RT (QUAD Shot: 14 Gy in 4 fractions, twice-daily treatments with 6 hours interval on 2 consecutive days) can be a practical RT regimen for those patients. In this report, we present the successful treatment course of repeated QUAD Shots in a 79-year-old patient with neglected skin cancer that was disfiguring his face yet declined definitive surgery and protracted RT. We also evaluated and compared biologically equivalent doses between QUAD Shots and conventionally fractionated protracted RT regimens.
机译:尽管手术是局部治疗皮肤癌的主要手段,但最终放射疗法(RT)也已用于不能耐受手术的患者。明确的放疗方案通常包括每天治疗4-7周。但是,对于不依从的患者或无法连续数周进行每日多次旅行的患者,这种长期的每日RT方案不可行。但是,如果不进行治疗,皮肤癌会不断发展并引起令人痛苦的症状。对于这些患者,周期性的低剂量放疗(QUAD Shot:4次14 Gy,每天两次,间隔2小时,连续2天,每天两次)是可行的放疗方案。在本报告中,我们介绍了对一名79岁的被忽视的皮肤癌患者进行重复QUAD Shots治疗的成功过程,该患者的面部容颜已变,但最终手术拒绝且RT延长。我们还评估并比较了QUAD Shots和常规分次延长的RT方案之间的生物学等效剂量。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号